E1 ReplicatedModerate confidencePEM unclearRCTPeer-reviewedMachine draft
Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial.
van Der Schaaf, Marieke E, Schmits, Iris C, Roerink, Megan et al. · BMC psychiatry · 2015 · DOI
Quick Summary
This study investigated how cognitive behavioral therapy (CBT) works for ME/CFS by examining brain imaging and blood markers before and after treatment. Researchers compared 60 ME/CFS patients receiving CBT with 30 on a waiting list and 30 healthy controls to see how their brains changed and whether hormone and immune markers were involved in recovery.
Why It Matters
Understanding how CBT changes brain function and biology in ME/CFS could validate neural mechanisms of the illness and identify which patients are likely to benefit, potentially improving treatment selection and outcomes.
Observed Findings
- This is a registered protocol describing planned methodology; specific findings from analysis are not reported in this abstract.
Inferred Conclusions
- The authors propose that central neural mechanisms contribute to CFS fatigue and disability.
- They hypothesize that CBT's therapeutic effect involves measurable changes in brain anatomy, function, and neuroendocrine-immune markers.
- They suggest that integrating neuroimaging, endocrinology, and immunology may improve understanding of treatment response heterogeneity.
Remaining Questions
- Which specific brain regions show structural or functional changes in CBT responders versus non-responders?
- What is the relationship between cortisol/cytokine changes and clinical improvement in fatigue and disability?
- Do baseline neuroimaging or biomarker patterns predict which patients will benefit from CBT?
- How do neural, endocrine, and immune markers relate to one another in determining treatment outcomes?
What This Study Does Not Prove
This protocol does not establish that neural or endocrine changes are the primary cause of ME/CFS symptoms, only that they may correlate with symptom improvement. The study cannot prove CBT is curative or universally effective, and the waiting-list design does not control for placebo effects.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesNeuroimagingBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionStrong Phenotyping
Metadata
- DOI
- 10.1186/s12888-015-0515-9
- PMID
- 26138726
- Review status
- Machine draft
- Evidence level
- Replicated human evidence from multiple independent studies
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →